Operating
Other Working Capital
United Therapeutics Other Working Capital decreased by 127.5% to -$27.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 79.9%, from -$134.50M to -$27.00M. Over 3 years (FY 2021 to FY 2025), Other Working Capital shows a downward trend with a -10.5% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
Large fluctuations may indicate timing differences in tax payments, accruals, or other non-core operational shifts.
Detailed definition
Captures the net impact of changes in operating assets and liabilities not categorized as accounts receivable, inventory...
Peer comparison
Varies significantly by industry; peers with similar business models should show comparable trends in accrual management.
Metric ID:
change_in_other_working_capitalHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $71.50M | $18.60M | $12.60M | -$44.90M | $130.50M | -$29.30M | $94.30M | -$41.00M | $78.20M | $4.30M | -$75.50M | $136.40M | -$42.40M | -$27.00M | -$134.50M | $184.40M | -$67.20M | $98.20M | -$27.00M |
| QoQ Change | — | -74.0% | -32.3% | -456.3% | +390.6% | -122.5% | +421.8% | -143.5% | +290.7% | -94.5% | <-999% | +280.7% | -131.1% | +36.3% | -398.1% | +237.1% | -136.4% | +246.1% | -127.5% |
| YoY Change | — | — | — | — | +82.5% | -257.5% | +648.4% | +8.7% | -40.1% | +114.7% | -84.1% | +74.4% | <-999% | — | -78.1% | +35.2% | -58.5% | +463.7% | +79.9% |
Range-$134.50M – $184.40M
CAGR-19.5%
Avg YoY Growth-6.9%
Median YoY Growth+21.9%
Other Working Capital at Other Companies
Frequently Asked Questions
- What is United Therapeutics's other working capital?
- United Therapeutics (UTHR) reported other working capital of -$27.00M in Q1 2026.
- How has United Therapeutics's other working capital changed year-over-year?
- United Therapeutics's other working capital increased by 79.9% year-over-year, from -$134.50M to -$27.00M.
- What is the long-term trend for United Therapeutics's other working capital?
- Over 3 years (2021 to 2025), United Therapeutics's other working capital has grown at a -10.5% compound annual growth rate (CAGR), from $112.90M to $80.90M.
- What does other working capital mean?
- Net cash impact from changes in miscellaneous operating assets and liabilities.